A tighter archive for life-science signals.
Search once, then narrow by source or topic.
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Markets Financial Content
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call Markets Financial Content
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Markets Financial Content
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call Markets Financial Content
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call - Yahoo Finance
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call Yahoo Finance
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript Insider Monkey
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics - PR Newswire
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics PR Newswire
Have 10x Genomics Insiders Been Selling Stock? - simplywall.st
Have 10x Genomics Insiders Been Selling Stock? simplywall.st
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - PR Newswire
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery PR Newswire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page